Call for Abstracts for the 2016 International Neuroethics Society Annual Meeting

International Neuroethics Society
Sunday, March 27, 2016 - Wednesday, June 01, 2016
Present your research to colleagues from around the world at the 2016 Annual Meeting of the International Neuroethics Society in San Diego, CA, November 10-11, 2016. The Society encourages investigators at all stages of their careers to submit abstracts of both an empirical and philosophical nature related to the field of neuroethics. Acceptance will be based on content, available space, and overall program balance. All oral and poster presentations will take place on Friday, November 11, 2016.


Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain

The New York Academy of Sciences
New York, NY
Tuesday, June 21, 2016
Surgery helps millions of Americans overcome illness to live longer, healthier lives. Yet for many of these people, surgery can lead to delirium, cognitive decline, and perhaps even a higher long-term risk of dementia. These risks are poorly understood and often under-recognized in the clinic. The level of risk to a patient depends on the individual and the surgery. For example, delirium is experienced in 15–80% of surgical patients who, in turn, may have a higher risk of long-term cognitive and functional decline. This one-day meeting will convene leading scientists to discuss the challenges and opportunities to create biomarkers and therapeutics for these vulnerable patients.


Multiple Sclerosis: Diagnostic and Treatment Frontiers

The New York Academy of Sciences
New York, NY
Tuesday, June 28, 2016
Multiple sclerosis (MS)—a disease of the central nervous system—causes damage to the myelin that protects axons in the brain, leading to inflammation and damage and thereby disrupting nerve impulses. Given the widespread prevalence and the disabling effects of this neurological condition, it is critical that diagnostics and treatments for MS continue to improve. This one-day, translational conference will address these issues.


ENCODS 2016: European Neuroscience Conference for Doctoral Students

ENCODS
Helsingør, Denmark
Wednesday, June 29, 2016 - Friday, July 01, 2016
ENCODS believes that open-minded interaction with fellow neuroscientists, and beyond, is key to move the field forward. Therefore, the aim of the ENCODS 2016 is threefold:1. To inspire young scientists to look beyond the boundaries of their own field; 2. To provide an intimate environment where young researchers can interact with both renowned scientists and fellow researchers; 3. To help students develop a skill set that is needed to be a good communicator of science.


Academy of Neuroscience for Architecture 2016: BridgeSYNAPSES

Academy of Neuroscience for Architecture
La Jolla, CA
Thursday, September 22, 2016 - Saturday, September 24, 2016
The ANFA Conference will explore, from a scientific basis, the range of human experiences with elements of architecture, through a collaboration between architects and neuroscientists. We invite neuroscientists, architects and other professionals to present research and research-based design that will illuminate the neuroscience of the experience of architecture and design of the built environment, as well as the use of insights from neuroscience to develop new approaches to the design of intelligent buildings.


Emerging Paradigms in Drug Discovery & Chemical Biology

The New York Academy of Sciences
New York, NY
Tuesday, October 25, 2016
Chemical Biology is changing the face of drug discovery. Over the past decade, chemistry based approaches have facilitated unprecedented advances in our understanding of cell biology and animal physiology, and have proven highly useful for drug discovery, demonstrating success not only in target and mechanism identification, but also in target validation and off-target identification. This symposium will highlight recent advances in on-target and off-target identification of drug-protein interactions in physiologically relevant systems, and will feature talks on the ubiquitin proteasome system, GPCRs, protein lipidation mechanisms, neurobiology, and cancer.


Alzheimer's Disease as a Neurovascular Inflammatory Disorder

The New York Academy of Sciences
New York, NY
Tuesday, December 06, 2016
Alzheimer’s disease (AD) constitutes a significant socioeconomic burden, which will only continue to increase as the global population ages. Significant headway into elucidating disease mechanisms has been made, however this progress has not translated into effective strategies for preventing, treating, or curing this crippling disorder. Emerging research suggests a strong link between brain vascular dysfunction and AD. However, despite mounting evidence for vascular pathology in AD, its role in etiology is hotly debated. As a result, there is a clear need to map the molecular and cellular mechanisms that link vascular disease and AD. This symposium will highlight basic research and clinical science elucidating the mechanisms underlying vascular contributions to cognitive impairment and dementia (VCID).